{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:39:47Z","timestamp":1793115587127,"version":"4.5.0"},"reference-count":253,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.heliyon.2023.e17478","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T22:35:49Z","timestamp":1687386949000},"page":"e17478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plausibility of natural immunomodulators in the treatment of COVID-19\u2013A comprehensive analysis and future recommendations"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3880-3373","authenticated-orcid":false,"given":"Raushanara","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rashidur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-949X","authenticated-orcid":false,"given":"Zainab Syed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-3793","authenticated-orcid":false,"given":"Afrina","family":"Afrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e17478_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/molecules25215017","article-title":"Antiviral and immunomodulatory effects of phytochemicals from honey against COVID-19: potential mechanisms of action and future directions","volume":"25","author":"Al-Hatamleh","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtcme.2020.12.001","article-title":"Anti-COVID-19 drug candidates: a review on potential biological activities of natural products in the management of new coronavirus infection","volume":"11","author":"Prasansuklab","year":"2021","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.heliyon.2023.e17478_bib3","article-title":"Traditional herbal medicine candidates as complementary treatments for COVID-19: a review of their mechanisms, pros and cons","volume":"2020","author":"Nugraha","year":"2020","journal-title":"Evid. Base. Compl. Alternat. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bmjnph-2020-000085","article-title":"Nutrition, immunity and COVID-19","volume":"3","author":"Calder","year":"2020","journal-title":"BMJ Nutr. Prev. Health"},{"issue":"10223","key":"10.1016\/j.heliyon.2023.e17478_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17478_bib6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.200909-1427SO","article-title":"Innate immune recognition in infectious and noninfectious diseases of the lung","volume":"181","author":"Opitz","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib7","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3389\/fphar.2020.583777","article-title":"Calming the storm: natural immunosuppressants as adjuvants to target the cytokine storm in COVID-19","volume":"11","author":"Peter","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib8","doi-asserted-by":"crossref","unstructured":"A. S. S. Girija, E. M. Shankar, and M. Larsson, \u201cCould SARS-CoV-2-induced hyperinflammation magnify the severity of coronavirus disease (CoViD-19) leading to acute respiratory distress syndrome?,\u201d Front. Immunol., vol. 11, p. 1206, May 2020, doi: 10.3389\/FIMMU.2020.01206\/BIBTEX.","DOI":"10.3389\/fimmu.2020.01206"},{"key":"10.1016\/j.heliyon.2023.e17478_bib9","series-title":"Characteristics of Lymphocyte Subsets and Cytokines in Peripheral Blood of 123 Hospitalized Patients with 2019 Novel Coronavirus Pneumonia","author":"Wan","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e17478_bib10","series-title":"A Systematic Review of Antibody Mediated Immunity to Coronaviruses: Antibody Kinetics, Correlates of Protection, and Association of Antibody Responses with Severity of Disease","author":"Huang","year":"2020"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17478_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: immunopathogenesis and Immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib13","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib14","doi-asserted-by":"crossref","unstructured":"K. Khanna et al., \u201cHerbal immune-boosters: substantial warriors of pandemic Covid-19 battle,\u201d Phytomedicine, vol. 85, p. 153361, May 2021, doi: 10.1016\/J.PHYMED.2020.153361.","DOI":"10.1016\/j.phymed.2020.153361"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2023.e17478_bib16","doi-asserted-by":"crossref","DOI":"10.1590\/0001-3765201920190105","article-title":"The role of natural products in modern drug discovery","volume":"91","author":"Calixto","year":"2019","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.heliyon.2023.e17478_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.575877","article-title":"Naturally occurring bioactives as antivirals: emphasis on coronavirus infection","volume":"vol. 12","author":"Ayatollahi","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17478_bib18","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/pr9101814","article-title":"Identifying the most potent dual-targeting compound(s) against 3CLprotease and NSP15exonuclease of SARS-CoV-2 from nigella sativa: virtual screening via physicochemical properties, docking and dynamic simulation analysis","volume":"9","author":"Rizvi","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.heliyon.2023.e17478_bib19","series-title":"American Journal of Pathology","first-page":"4","article-title":"Immunopathology of hyperinflammation in COVID-19","volume":"vol. 191","author":"Gustine","year":"2021"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17478_bib20","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy: Eur. J. Allergy Clin. Immunol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19\u2014immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8020061","article-title":"The mechanism of action of ursolic acid as a potential anti-toxoplasmosis agent, and its immunomodulatory effects","volume":"8","author":"Choi","year":"2019","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.5642","article-title":"COVID-19: immunopathology, pathophysiological mechanisms, and treatment options","volume":"254","author":"van Eijk","year":"2021","journal-title":"J. Pathol."},{"issue":"6585","key":"10.1016\/j.heliyon.2023.e17478_bib24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"1979","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19706-9","article-title":"Immune suppression in the early stage of COVID-19 disease","volume":"11","author":"Tian","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17478_bib30","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e17478_bib31","doi-asserted-by":"crossref","unstructured":"J. F. Bermejo-Martin, R. Almansa, R. Men\u00e9ndez, R. Mendez, D. J. Kelvin, and A. Torres, \u201cLymphopenic community acquired pneumonia as signature of severe COVID-19 infection,\u201d J. Infect., vol. 80, no. 5, pp. e23\u2013e24, May 2020, doi: 10.1016\/J.JINF.2020.02.029.","DOI":"10.1016\/j.jinf.2020.02.029"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17478_bib32","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood-2011-01-330639","article-title":"Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells","volume":"118","author":"Prinz","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17478_bib33","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"12","author":"Wang","year":"2020","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.13523","article-title":"Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage","volume":"202","author":"Amor","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"10224","key":"10.1016\/j.heliyon.2023.e17478_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e17478_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fgene.2020.00641","article-title":"Neutrophils, crucial, or harmful immune cells involved in coronavirus infection: a bioinformatics study","volume":"11","author":"Hemmat","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.heliyon.2023.e17478_bib37","doi-asserted-by":"crossref","unstructured":"J. Shang et al., \u201cCell entry mechanisms of SARS-CoV-2,\u201d Proc. Natl. Acad. Sci. U. S. A., vol. 117, no. 21, pp. 11727\u201311734, May 2020, doi: 10.1073\/PNAS.2003138117\/SUPPL_FILE\/PNAS.2003138117.SD01.XLSX.","DOI":"10.1073\/pnas.2003138117"},{"key":"10.1016\/j.heliyon.2023.e17478_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.heliyon.2023.e17478_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","author":"Garc\u00eda","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17478_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","article-title":"The ORF3a protein of SARS-CoV-2 induces apoptosis in cells","volume":"17","author":"Ren","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2023.e17478_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041356","article-title":"Double-stranded RNA sensors and modulators in innate immunity","volume":"37","author":"Hur","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17478_bib43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imm.13262","article-title":"T-cell responses and therapies against SARS-CoV-2 infection","volume":"162","author":"Toor","year":"2021","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17478_bib46","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1002\/jmv.26183","article-title":"Impact of comorbidities on patients with COVID-19: a large retrospective study in Zhejiang, China","volume":"92","author":"Ye","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib47","doi-asserted-by":"crossref","unstructured":"J. B. Moore and C. H. June, \u201cCytokine release syndrome in severe COVID-19,\u201d Science, vol. 368, no. 6490, pp. 473\u2013474, May 2020, doi: 10.1126\/SCIENCE.ABB8925.","DOI":"10.1126\/science.abb8925"},{"key":"10.1016\/j.heliyon.2023.e17478_bib48","series-title":"Cytokine and Growth Factor Reviews","first-page":"66","article-title":"COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"vol. 53","author":"Nile","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e17478_bib49","series-title":"Frontiers in Immunology","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"vol. 11","author":"Ragab","year":"2020"},{"issue":"564","key":"10.1016\/j.heliyon.2023.e17478_bib50","article-title":"Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients","volume":"12","author":"Adom","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00263-y","article-title":"Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib54","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/JVI.77.4.2530-2538.2003","article-title":"Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E","volume":"77","author":"Bonavia","year":"2003","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"15","key":"10.1016\/j.heliyon.2023.e17478_bib56","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","volume":"71","author":"Guo","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17478_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00797-20","article-title":"The role of antibody testing for sars-cov-2: is there one?","volume":"58","author":"Theel","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"10328","key":"10.1016\/j.heliyon.2023.e17478_bib58","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib59","first-page":"1","article-title":"A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17478_bib60","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e17478_bib61","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib62","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2020.11.191","article-title":"A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness","volume":"103","author":"Ahmed","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5005\/jp-journals-10018-1317","article-title":"Treatment of COVID-19 patients at a medical College hospital in Bangladesh","volume":"10","author":"Akbar","year":"2020","journal-title":"Euroasian J. Hepato-Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib64","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2147\/RMHP.S265030","article-title":"Current options in the treatment of COVID-19: a review","volume":"13","author":"Teimury","year":"2020","journal-title":"Risk Manag. Healthc. Pol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib65","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Lamontagne","year":"2020","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17478_bib66","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40264-020-00976-7","article-title":"Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines","volume":"43","author":"Sultana","year":"2020","journal-title":"Drug Saf."},{"issue":"10279","key":"10.1016\/j.heliyon.2023.e17478_bib67","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(21)00461-X","article-title":"Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"397","author":"Butler","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e17478_bib68","series-title":"Molnupiravir | COVID-19 Treatment Guidelines","year":"2022"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib69","article-title":"Therapeutic management of patients with COVID-19: a systematic review","volume":"2","author":"Tobaiqy","year":"2020","journal-title":"Infect. Prev. Pract."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1871529X21666210812103535","article-title":"Cardiovascular considerations of remdesivir and favipiravir in the treatment of COVID-19","volume":"21","author":"Shahrbaf","year":"2021","journal-title":"Cardiovasc. Haematol. Disord. - Drug Targets"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib71","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.mayocpiqo.2021.03.007","article-title":"Anti-inflammatory treatment of COVID-19 pneumonia with tofacitinib alone or in combination with dexamethasone is safe and possibly superior to dexamethasone as a single agent in a predominantly african American cohort","volume":"5","author":"Hayek","year":"2021","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40121-021-00545-0","article-title":"Efficacy and safety of immunomodulators in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials","volume":"11","author":"Ngamprasertchai","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.heliyon.2023.e17478_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173451","article-title":"COVID-19: a review of the proposed pharmacological treatments","volume":"886","author":"Lam","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.heliyon.2023.e17478_bib74","article-title":"Immunomodulatory properties of macrolides: overview and historical perspective","volume":"117","author":"Rubin","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib75","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2023.e17478_bib76","article-title":"Systematic review of immunosuppressant guidelines in the COVID-19 pandemic","volume":"12","author":"Barlow-Pay","year":"2021","journal-title":"Adv. Drug Saf."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib77","first-page":"609","article-title":"Tocilizumab a review of its use in the management of rheumatoid arthritis","volume":"69","author":"Dhillon","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.heliyon.2023.e17478_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01844","article-title":"Immunomodulatory drugs in the management of SARS-CoV-2","volume":"11","author":"Burrage","year":"2020","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e17478_bib79","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2023.e17478_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00778","article-title":"Sources of type I interferons in infectious immunity: plasmacytoid dendritic cells not always in the driver's seat","volume":"10","author":"Ali","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19","volume":"178","author":"Sallard","year":"2020","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib82","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/ehm.12.62","article-title":"Immunomodulatory drugs in multiple myeloma","volume":"6","author":"Andhavarapu","year":"2013","journal-title":"Expert Rev. Hematol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib83","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/14656566.2022.2035360","article-title":"Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)","volume":"23","author":"McCarthy","year":"2022","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e17478_bib84","doi-asserted-by":"crossref","unstructured":"C. Zhang, Z. Wu, J. W. Li, H. Zhao, and G. Q. Wang, \u201cCytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality,\u201d Int. J. Antimicrob. Agents, vol. 55, no. 5, May 2020, doi: 10.1016\/j.ijantimicag.2020.105954.","DOI":"10.1016\/j.ijantimicag.2020.105954"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib85","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01833-6","article-title":"The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial","volume":"22","author":"Ghanei","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2023.e17478_bib86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05990","article-title":"Can Echinacea be a potential candidate to target immunity, inflammation, and infection - the trinity of coronavirus disease 2019","volume":"7","author":"Nagoor Meeran","year":"2021","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib88","doi-asserted-by":"crossref","first-page":"786","DOI":"10.5530\/pj.2017.6.123","article-title":"Immunomodulatory activity of bioactive fraction (PBC) from phyllostachys bambusoides","volume":"9","author":"Kumar","year":"2017","journal-title":"Phcog. J."},{"key":"10.1016\/j.heliyon.2023.e17478_bib89","doi-asserted-by":"crossref","unstructured":"H. Cena and M. Chieppa, \u201cCoronavirus disease (COVID-19\u2013SARS-CoV-2) and nutrition: is infection in Italy suggesting a connection?,\u201d Front. Immunol., vol. 11, May 2020, doi: 10.3389\/FIMMU.2020.00944\/FULL.","DOI":"10.3389\/fimmu.2020.00944"},{"key":"10.1016\/j.heliyon.2023.e17478_bib90","doi-asserted-by":"crossref","DOI":"10.5772\/66112","article-title":"Plant phenolic compounds as immunomodulatory agents","author":"Grigore","year":"2017","journal-title":"Phenolic Comp. - Biol. Activ."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e17478_bib91","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-immunomodulatory therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17478_bib92","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/a-1177-4396","article-title":"Challenges at the time of COVID-19: opportunities and innovations in antivirals from nature","volume":"86","author":"Hensel","year":"2020","journal-title":"Planta Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib93","doi-asserted-by":"crossref","unstructured":"I. Jantan, W. Ahmad, and S. N. A. Bukhari, \u201cPlant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials,\u201d Front. Plant Sci., vol. 6, no. AUG, Aug. 2015, doi: 10.3389\/FPLS.2015.00655\/FULL.","DOI":"10.3389\/fpls.2015.00655"},{"key":"10.1016\/j.heliyon.2023.e17478_bib94","doi-asserted-by":"crossref","unstructured":"A. Z. Reyes et al., \u201cAnti-inflammatory therapy for COVID-19 infection: the case for colchicine,\u201d Ann. Rheum. Dis., vol. 80, no. 5, pp. 550\u2013557, May 2021, doi: 10.1136\/ANNRHEUMDIS-2020-219174.","DOI":"10.1136\/annrheumdis-2020-219174"},{"issue":"720","key":"10.1016\/j.heliyon.2023.e17478_bib95","doi-asserted-by":"crossref","first-page":"E446","DOI":"10.3399\/BJGP.2022.0083","article-title":"Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial","volume":"72","author":"Dorward","year":"2022","journal-title":"Br. J. Gen. Pract."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib96","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001455","article-title":"Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial","volume":"7","author":"Lopes","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.heliyon.2023.e17478_bib97","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8865954","article-title":"A case control study to evaluate the impact of colchicine on patients admitted to the hospital with moderate to severe covid-19 infection","volume":"2020","author":"Sandhu","year":"2020","journal-title":"Can. J. Infect Dis. Med. Microbiol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib98","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13424-6","article-title":"Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial","volume":"12","author":"Cecconi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2023.e17478_bib100","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.2147\/IJGM.S329810","article-title":"Colchicine in recently hospitalized patients with COVID-19: a randomized controlled trial (COL-COVID)","volume":"14","author":"Pascual-Figal","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib101","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ptr.6855","article-title":"Piperine: a review of its biological effects","volume":"35","author":"Haq","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2023.e17478_bib102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-319-41334-1_8","article-title":"Piperine and its role in chronic diseases","volume":"928","author":"Derosa","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13337-020-00598-8","article-title":"Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor","volume":"31","author":"Maurya","year":"2020","journal-title":"Virusdisease"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17478_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101434","article-title":"Plant alkaloids inhibit membrane fusion mediated by calcium and fragments of mers-cov and sars-cov\/sars-cov-2 fusion peptides","volume":"9","author":"Shekunov","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib105","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-021-02685-z","article-title":"Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-\u03b2 and TNF-\u03b1","volume":"11","author":"Manne","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.heliyon.2023.e17478_bib106","unstructured":"M. Manne, V. Validandi, and A. L. Khandare, REDUCTION OF FLUORIDE TOXICITY BY TAMARIND COMPONENTS: AN IN SILICO STUDY."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib107","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib108","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib109","article-title":"Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer","volume":"10","author":"O'Connell","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib110","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s10787-022-01080-1","article-title":"The role of berberine in Covid-19: potential adjunct therapy","volume":"30","author":"Babalghith","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.heliyon.2023.e17478_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.669642","article-title":"Myricetin inhibits SARS-CoV-2 viral replication by targeting Mpro and ameliorates pulmonary inflammation","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17478_bib112","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmcl.2012.04.081","article-title":"Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13","volume":"22","author":"Yu","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.heliyon.2023.e17478_bib113","series-title":"Plant Metabolites and Regulation under Environmental Stress","first-page":"195","article-title":"Metabolic responses of plants upon different plant-pathogen interactions","author":"Matilla","year":"2018"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib114","article-title":"Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications","volume":"20","author":"Taheri","year":"2020","journal-title":"BMC Compl. Med. Ther."},{"key":"10.1016\/j.heliyon.2023.e17478_bib115","series-title":"FooDB","year":"2022"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib116","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4196\/kjpp.2015.19.5.441","article-title":"Scutellarein reduces inflammatory responses by inhibiting Src kinase activity","volume":"19","author":"Sung","year":"2015","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"issue":"21","key":"10.1016\/j.heliyon.2023.e17478_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216744","article-title":"Characterization of the trans-epithelial transport of green tea (C. sinensis) catechin extracts with in vitro inhibitory effect against the sars-cov-2 papain-like protease activity","volume":"26","author":"Montone","year":"2021","journal-title":"Molecules"},{"issue":"Jul","key":"10.1016\/j.heliyon.2023.e17478_bib118","article-title":"Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2","volume":"203","author":"Attia","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.heliyon.2023.e17478_bib119","series-title":"Immunomodulatory Effect of Rutin, Catechin, and Hesperidin on Macrophage Function","author":"Ganeshpurkar","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e17478_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/393217","article-title":"Hesperidin inhibits inflammatory response induced by aeromonas hydrophila infection and alters CD4+\/CD8+ T cell ratio","volume":"2014","author":"Abuelsaad","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17478_bib121","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1248\/bpb.23.1122","article-title":"In vitro inhibitory effect of some flavonoids on rotavirus infectivity","volume":"23","author":"Bae","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2023.e17478_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/3125662","article-title":"Fourteen-day evolution of COVID-19 symptoms during the third wave in nonvaccinated subjects and effects of hesperidin therapy: a randomized, double-blinded, placebo-controlled study","volume":"2022","author":"Dupuis","year":"2022","journal-title":"Evid. Base. Compl. Alternat. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib123","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/10942912.2016.1207188","article-title":"Health functionality of apigenin: a review","volume":"20","author":"Ali","year":"2017","journal-title":"Int. J. Food Prop."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040858","article-title":"A comprehensive assessment of apigenin as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound","volume":"11","author":"Ghi\u021bu","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2023.e17478_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00051","article-title":"Immunomodulatory effects of flavonoids: possible induction of T CD4+ regulatory cells through suppression of mTOR pathway signaling activity","volume":"10","author":"Hosseinzade","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib126","unstructured":"J. Kowalski, A. Samojedny, M. Paul, G. Pietsz, and T. Wilczok, \u201cEffect of apigenin, kaempferol and resveratrol on the expression of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 genes in J774.2 macrophages,\u201d Pharmacol. Rep., vol. 57, no. 3, pp. 390\u2013394, May 2005."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib127","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0041-1345(02)02795-1","article-title":"Flavonoids exert diverse inhibitory effects on the activation of NF-\u03baB","volume":"34","author":"Muraoka","year":"2002","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib128","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1080\/21655979.2022.2027181","article-title":"Apigenin analogues as SARS-CoV-2 main protease inhibitors: in-silico screening approach","volume":"13","author":"Farhat","year":"2022","journal-title":"Bioengineered"},{"issue":"22","key":"10.1016\/j.heliyon.2023.e17478_bib129","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","article-title":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition","volume":"18","author":"Ryu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e17478_bib130","unstructured":"S. M. Abdelgawad, Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients Sponsor: Information provided by (Responsible Party): Good Times [Online]. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT048733491\/8."},{"key":"10.1016\/j.heliyon.2023.e17478_bib131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2017.07.017","article-title":"Immunomodulatory potential of hesperetin and chrysin through the cellular and humoral response","volume":"812","author":"Sassi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib132","first-page":"293","article-title":"Role of flavonoids in management of inflammatory disorders","author":"Shukla","year":"2019","journal-title":"Bioact. Food Diet. Interv. Arthritis Relat. Inflamm. Dis."},{"key":"10.1016\/j.heliyon.2023.e17478_bib133","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.biopha.2017.06.003","article-title":"An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances","volume":"92","author":"Zeinali","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e17478_bib134","article-title":"Silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors","author":"Hashem","year":"2020","journal-title":"Eurasian J. Med. Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17478_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26123755","article-title":"Immunomodulatory effects of green tea polyphenols","volume":"26","author":"Wang","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib136","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4062\/biomolther.2015.036","article-title":"Fisetin suppresses macrophage-mediated inflammatory responses by blockade of Src and Syk","volume":"23","author":"Kim","year":"2015","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.heliyon.2023.e17478_bib137","first-page":"2759","article-title":"Recent progress regarding kaempferol for the treatment of various diseases","author":"Ren","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib138","series-title":"Fisetin Induces Apoptosis in Human Cervical Cancer HeLa Cells through ERK1\/2-Mediated Activation of Caspase-8-\/caspase-3-dependent Pathway","author":"Ying","year":"2011"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17478_bib139","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1111\/jgs.17416","article-title":"Fisetin for COVID-19 in skilled nursing facilities: senolytic trials in the COVID era","volume":"69","author":"Verdoorn","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.heliyon.2023.e17478_bib140","unstructured":"J. L. Kirkland and M. Clinic, COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation Sponsor: Mayo Clinic Information provided by (Responsible Party): Go to."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9020180","article-title":"Pharmacological targets of kaempferol within inflammatory pathways\u2014a hint towards the central role of tryptophan metabolism","volume":"9","author":"Hofer","year":"2020","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib142","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3390\/molecules16043338","article-title":"Kaempferol and kaempferol rhamnosides with depigmenting and anti-inflammatory properties","volume":"16","author":"Rho","year":"2011","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib143","first-page":"11","article-title":"Antitumor activity of flavonoids on NK\/Ly ascites tumor cells","volume":"28","author":"Molnar","year":"1981","journal-title":"Neoplasma"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib144","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3892\/etm.2016.3854","article-title":"Anti-inflammatory effects of luteolin on experimental autoimmune thyroiditis in mice","volume":"12","author":"Xia","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-6-29","article-title":"Luteolin as a therapeutic option for multiple sclerosis","volume":"6","author":"Theoharides","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.heliyon.2023.e17478_bib146","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-0-387-72005-0_45","article-title":"Mast Cells, T Cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis","volume":"601","author":"Theoharides","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib147","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.104.008193","article-title":"Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases","volume":"67","author":"Beeton","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib148","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2014.03.009","article-title":"Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway","volume":"71","author":"Xu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e17478_bib149","doi-asserted-by":"crossref","first-page":"11334","DOI":"10.1128\/JVI.78.20.11334-11339.2004","article-title":"Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells","volume":"78","author":"Yi","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.antiviral.2008.10.002","article-title":"Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus","volume":"81","author":"Choi","year":"2009","journal-title":"Antivir. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib151","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s12192-016-0734-0","article-title":"Effect of heated naringenin on immunomodulatory properties and cellular antioxidant activity","volume":"21","author":"Maatouk","year":"2016","journal-title":"Cell Stress Chaperones"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib152","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.foodchem.2006.11.054","article-title":"Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review","volume":"104","author":"Tripoli","year":"2007","journal-title":"Food Chem."},{"key":"10.1016\/j.heliyon.2023.e17478_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/102457","article-title":"Flavonoid naringenin: a potential immunomodulator for Chlamydia trachomatis inflammation","volume":"2013","author":"Yilma","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25041017","article-title":"Potential therapeutic anti\u2010inflammatory and immunomodulatory effects of dihydroflavones, flavones, and flavonols","volume":"25","author":"Zaragoz\u00e1","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e17478_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105255","article-title":"Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro","volume":"163","author":"Clementi","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib156","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/cells10051130","article-title":"The discovery of naringenin as endolysosomal two-pore channel inhibitor and its emerging role in SARS-CoV-2 infection","volume":"10","author":"D'Amore","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib157","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jtcme.2021.01.006","article-title":"Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins","volume":"11","author":"Rahman","year":"2021","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.heliyon.2023.e17478_bib158","series-title":"Immunomodulatory Effect of Rutin, Catechin, and Hesperidin on Macrophage Function","author":"Ganeshpurkar","year":"2020"},{"key":"10.1016\/j.heliyon.2023.e17478_bib159","doi-asserted-by":"crossref","unstructured":"A. Boufissiou et al., \u201cIn-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro PDB ID:5R83) using a virtual screening method,\u201d J. Saudi Chem. Soc., vol. 26, no. 3, May 2022, doi: 10.1016\/j.jscs.2022.101473.","DOI":"10.1016\/j.jscs.2022.101473"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib160","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/ijms16011736","article-title":"Apigenin-7-glycoside prevents LPS-induced acute lung injury via downregulation of oxidative enzyme expression and protein activation through inhibition of MAPK phosphorylation","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib161","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1007\/s13277-015-4635-0","article-title":"Immunomodulatory and cellular antioxidant activities of pure compounds from Teucrium ramosissimum Desf","volume":"37","author":"Nasr-Bouzaiene","year":"2016","journal-title":"Tumor Biol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e17478_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20122957","article-title":"Quercetin inhibits the production of il-1\u03b2-induced inflammatory cytokines and chemokines in arpe-19 cells via the mapk and nf-\u03bab signaling pathways","volume":"20","author":"Cheng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21040450","article-title":"Anti-inflammatory effect of quercetin on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid","volume":"21","author":"Kim","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib164","article-title":"Immunomodulatory properties of quercetin-3-O-\u03b1-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus","volume":"18","author":"Mehrbod","year":"2018","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib165","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7039802","article-title":"Quercetin and quercitrin attenuates the inflammatory response and oxidative stress in LPS-induced RAW264.7 cells: in vitro assessment and a theoretical model","volume":"2019","author":"Tang","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib166","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/jn\/137.5.1208","article-title":"Quercetin inhibits TNF-induced NF-\u03baB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells","volume":"137","author":"Ruiz","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.heliyon.2023.e17478_bib167","unstructured":"Quercetin in the Treatment of SARS-COV 2 (QUERCOV) Go to."},{"key":"10.1016\/j.heliyon.2023.e17478_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01451","article-title":"Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)","volume":"11","author":"Colunga Biancatelli","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib169","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s10753-017-0542-4","article-title":"Quercetin and ascorbic acid suppress fructose-induced NLRP3 inflammasome activation by blocking intracellular shuttling of TXNIP in human macrophage cell lines","volume":"40","author":"Choe","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2023.e17478_bib170","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.3389\/fphar.2022.1096853","article-title":"Quercetin as a possible complementary agent for early-stage COVID-19: concluding results of a randomized clinical trial","volume":"13","author":"Di Pierro","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib171","unstructured":"H. Onal, K. Sultan, S. Training, and R. Hospital, Effect of Quercetin on Prophylaxis and Treatment of COVID-19 Information provided by (Responsible Party): Go to."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2021.05.003","article-title":"Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis","volume":"13","author":"Halder","year":"2022","journal-title":"J. Ayurveda Integr. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13030728","article-title":"Immunomodulatory effects of dietary polyphenols","volume":"13","author":"Shakoor","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17478_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111618","article-title":"The immunomodulatory and anti-inflammatory role of polyphenols","volume":"10","author":"Yahfoufi","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17478_bib175","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1002\/fsn3.1858","article-title":"Curcumin (a constituent of turmeric): new treatment option against COVID-19","volume":"8","author":"Babaei","year":"2020","journal-title":"Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","article-title":"\u2018Spicing up\u2019 of the immune system by curcumin","volume":"27","author":"Jagetia","year":"2007","journal-title":"J. Clin. Immunol."},{"issue":"Dec","key":"10.1016\/j.heliyon.2023.e17478_bib177","article-title":"Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients","volume":"89","author":"Valizadeh","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e17478_bib178","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ptr.6738","article-title":"Potential effects of curcumin in the treatment of COVID-19 infection","volume":"34","author":"Zahedipour","year":"2020","journal-title":"Phytother Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib179","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bgm.2014.06.002","article-title":"Curcumin decreased level of proinflammatory cytokines in monocyte cultures exposed to preeclamptic plasma by affecting the transcription factors NF-\u03baB and PPAR-\u03b3","volume":"6","author":"Rahardjo","year":"2014","journal-title":"Biomarkers Genom. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","article-title":"Immune modulation by curcumin: the role of interleukin-10","volume":"59","author":"Mollazadeh","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2023.e17478_bib181","doi-asserted-by":"crossref","unstructured":"K. S. Pawar et al., \u201cOral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: a randomized clinical trial,\u201d Front. Pharmacol., vol. 12, May 2021, doi: 10.3389\/FPHAR.2021.669362\/FULL.","DOI":"10.3389\/fphar.2021.669362"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib182","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ptr.6916","article-title":"Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells","volume":"35","author":"Yang","year":"2021","journal-title":"Phytother Res."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e17478_bib183","first-page":"7834","article-title":"Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors","volume":"24","author":"Ranjbar","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.heliyon.2023.e17478_bib184","unstructured":"M. Mccreary and C. H. System, Randomized Proof-Of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19 Information provided by (Responsible Party): Go to."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13920-9","article-title":"Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)","volume":"12","author":"McCreary","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib186","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13920-9","article-title":"Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)","volume":"12","author":"McCreary","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17478_bib187","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V96.9.2943","article-title":"Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy","volume":"96","author":"Hideshima","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib188","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s42485-021-00059-w","article-title":"Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors","volume":"12","author":"Vijayan","year":"2021","journal-title":"J. Protein Proteonomics"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib189","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0024-3205(97)01150-8","article-title":"Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages","volume":"62","author":"Visioli","year":"1998","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib190","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-2952(98)00320-7","article-title":"Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil","volume":"57","author":"De La Puerta","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib191","first-page":"267","article-title":"Therapeutic potential of ginger against COVID-19: is there enough evidence?","volume":"8","author":"Jafarzadeh","year":"2021","journal-title":"J. Tradit. Chin. Med. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib192","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/13880209.2014.920396","article-title":"Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response","volume":"53","author":"Khan","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib193","unstructured":"H. Onal, K. Sultan, S. Training, and R. Hospital, Effect of Quercetin on Prophylaxis and Treatment of COVID-19 Information provided by (Responsible Party): Go to."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17478_bib194","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1039\/C5FO00513B","article-title":"6-Gingerol modulates proinflammatory responses in dextran sodium sulfate (DSS)-treated Caco-2 cells and experimental colitis in mice through adenosine monophosphate-activated protein kinase (AMPK) activation","volume":"6","author":"Chang","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.heliyon.2023.e17478_bib195","article-title":"Attenuation of proinflammatory responses by S -[6]-Gingerol via inhibition of ROS\/NF-Kappa B\/COX2 activation in HuH7 cells","volume":"2013","author":"Li","year":"2013","journal-title":"Evid. base Compl. Alternative Med."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17478_bib196","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3109\/13880209.2015.1110598","article-title":"6-Gingerol inhibits Vibrio cholerae-induced proinflammatory cytokines in intestinal epithelial cells via modulation of NF-\u03baB","volume":"54","author":"Saha","year":"2016","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib197","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jss.2006.07.051","article-title":"Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages","volume":"138","author":"Tripathi","year":"2007","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.heliyon.2023.e17478_bib198","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.692423","article-title":"Inhibition of SARS CoV envelope protein by flavonoids and classical viroporin inhibitors","volume":"12","author":"Breitinger","year":"2021","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib199","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-020-00171-6","article-title":"Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: in silico evidence for cues from Ayurveda","volume":"7","author":"Haridas","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.heliyon.2023.e17478_bib200","doi-asserted-by":"crossref","unstructured":"T. Rathinavel, M. Palanisamy, S. Palanisamy, A. Subramanian, and S. Thangaswamy, \u201cPhytochemical 6-Gingerol \u2013 a promising Drug of choice for COVID-19,\u201d Int. J. Adv. Sci. Eng., vol. 6, no. 4, pp. 1482\u20131489, May 2020, doi: 10.29294\/IJASE.6.4.2020.1482-1489.","DOI":"10.29294\/IJASE.6.4.2020.1482-1489"},{"key":"10.1016\/j.heliyon.2023.e17478_bib201","unstructured":"Trial to Study the Efficacy and Safety of BEJO Red Ginger in COVID-19 Patients with Mild Symptoms Study Description Go to."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib202","first-page":"625","article-title":"Effects of ginger on clinical features and disease severity of patients with severe acute respiratory syndrome due to covid-19: a randomized controlled trial study","volume":"38","author":"Li","year":"2022","journal-title":"Acta Med. Mediterr."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.46234\/ccdcw2020.017","article-title":"A novel coronavirus genome identified in a cluster of pneumonia cases \u2014 wuhan, China 2019\u22122020","volume":"2","author":"Tan","year":"2020","journal-title":"China CDC Weekly"},{"issue":"52","key":"10.1016\/j.heliyon.2023.e17478_bib204","doi-asserted-by":"crossref","first-page":"32669","DOI":"10.1039\/C7RA04803C","article-title":"Essential oil eugenol: sources, extraction techniques and nutraceutical perspectives","volume":"7","author":"Khalil","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2023.e17478_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110179","article-title":"Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection","volume":"367","author":"Bahl","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fshw.2021.02.001","article-title":"Bioactive compounds and probiotics\u2013a ray of hope in COVID-19 management","volume":"10","author":"Bhushan","year":"2021","journal-title":"Food Sci. Hum. Wellness"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/hepo-2021-0009","article-title":"In silico studies of selected xanthophylls as potential candidates against SARS-CoV-2 targeting main protease (Mpro) and papain-like protease (PLpro)","volume":"67","author":"Karpi\u0144ski","year":"2021","journal-title":"Herba Pol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1760136","article-title":"Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach","author":"Enmozhi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2023.e17478_bib209","first-page":"1","article-title":"Therapeutic potentials of andrographolide from Andrographis paniculata : a review","author":"Maiti","year":"2006","journal-title":"J. Nat. Remedies"},{"key":"10.1016\/j.heliyon.2023.e17478_bib210","article-title":"Andrographis paniculata vs Boesenbergia rotunda vs control in asymptomatic COVID-19","year":"2023","journal-title":"Full Text View - ClinicalTrials.gov"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17478_bib211","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-2002-32556","article-title":"Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation","volume":"68","author":"Jae","year":"2002","journal-title":"Planta Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib212","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.33263\/BRIAC115.1291612924","article-title":"Molecular docking investigation of antiviral herbal compounds as potential inhibitors of sars-cov-2 spike receptor","volume":"11","author":"Fallah","year":"2021","journal-title":"Biointerface Res. Appl. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib213","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/ijms12020905","article-title":"Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice","volume":"12","author":"Li","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"9374","key":"10.1016\/j.heliyon.2023.e17478_bib214","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e17478_bib215","doi-asserted-by":"crossref","unstructured":"P. S. Suresh, S. Gupta, A. Sharma, and U. Sharma, An overview of coronaviruses: in-silico approach to decipher anti-SARS-CoV-2 Nat. Prod., doi: 10.26434\/chemrxiv.12782411.v1.","DOI":"10.26434\/chemrxiv.12782411.v1"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib216","doi-asserted-by":"crossref","DOI":"10.3390\/v13040609","article-title":"Glycyrrhizin effectively inhibits sars-cov-2 replication by inhibiting the viral main protease","volume":"13","author":"van de Sand","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2023.e17478_bib217","unstructured":"COMPOUND SUMMARY\u201d, doi: 10.5517\/cczwk0d."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib218","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4049\/jimmunol.174.1.426","article-title":"Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection","volume":"174","author":"Wang","year":"2005","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e17478_bib219","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2010.10.017","article-title":"Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6\/J mice through the inhibition of mast cell TNF-\u03b1 release","volume":"232","author":"Madera-Salcedo","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.25259\/IJPC_132_2021","article-title":"Morphine may contribute to improving respiratory failure in severe COVID-19: a case report","volume":"28","author":"Tanaka-Yagi","year":"2022","journal-title":"Indian J. Palliat. Care"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib221","first-page":"164","article-title":"Effects of morphine and fentanyl on patients with COVID-19","volume":"20","author":"Amirsavadkouhi","year":"2021","journal-title":"Tanaffos"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8020061","article-title":"The mechanism of action of ursolic acid as a potential anti-toxoplasmosis agent, and its immunomodulatory effects","volume":"8","author":"Choi","year":"2019","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib223","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ptr.3241","article-title":"Isolation of immunomodulatory triterpene acids from a standardized rose hip powder (Rosa canina L.)","volume":"25","author":"Saaby","year":"2011","journal-title":"Phytother Res."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e17478_bib224","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.2000208117","article-title":"A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2023.e17478_bib225","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clnesp.2021.12.030","article-title":"The possible role of ursolic acid in Covid-19: a real game changer","volume":"47","author":"Al-kuraishy","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17478_bib226","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2006-961504","article-title":"In vitro virucidal effects of Allium sativum (garlic) extract and compounds","volume":"58","author":"Weber","year":"1992","journal-title":"Planta Med."},{"key":"10.1016\/j.heliyon.2023.e17478_bib227","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.medidd.2020.100044","article-title":"Melatonin inhibits COVID-19-induced cytokine storm by reversing aerobic glycolysis in immune cells: a mechanistic analysis","volume":"6","author":"Reiter","year":"2020","journal-title":"Med. Drug. Discov."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib228","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-079X.2011.00943.x","article-title":"Inhibitory effects of melatonin on the lipopolysaccharide-induced CC chemokine expression in BV2 murine microglial cells are mediated by suppression of Akt-induced NF-\u03baB and STAT\/GAS activity","volume":"52","author":"Min","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.heliyon.2023.e17478_bib229","unstructured":"EU Clinical Trials Register Paediatric Regulatory Details\u201d."},{"key":"10.1016\/j.heliyon.2023.e17478_bib230","doi-asserted-by":"crossref","unstructured":"S. H. Lan, H. Z. Lee, C. M. Chao, S. P. Chang, L. C. Lu, and C. C. Lai, \u201cEfficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials,\u201d J. Med. Virol., vol. 94, no. 5, pp. 2102\u20132107, May 2022, doi: 10.1002\/JMV.27595.","DOI":"10.1002\/jmv.27595"},{"key":"10.1016\/j.heliyon.2023.e17478_bib231","unstructured":"Go to\u201d."},{"issue":"October","key":"10.1016\/j.heliyon.2023.e17478_bib232","first-page":"359","article-title":"Anti-viral effects of aqueous extracts of Aloe ferox and Withania somnifera on herpes simplex virus type 1 in cell culture","volume":"103","author":"Kambizi","year":"2007","journal-title":"South Afr. J. Sci."},{"issue":"43","key":"10.1016\/j.heliyon.2023.e17478_bib233","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1016\/j.vaccine.2009.07.011","article-title":"Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity","volume":"27","author":"Khan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2023.e17478_bib234","first-page":"1","article-title":"Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2023.e17478_bib235","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2147\/DDDT.S292805","article-title":"Withanone from withania somnifera attenuates sars-cov-2 rbd and host ace2 interactions to rescue spike protein induced pathologies in humanized zebrafish model","volume":"15","author":"Balkrishna","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2023.e17478_bib236","doi-asserted-by":"crossref","unstructured":"Q. Wu, S. Yan, Y. Wang, M. Li, Y. Xiao, and Y. Li, \u201cDiscovery of 4\u2032-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor,\u201d Biochem. Biophys. Res. Commun., vol. 604, pp. 76\u201382, May 2022, doi: 10.1016\/J.BBRC.2022.03.052.","DOI":"10.1016\/j.bbrc.2022.03.052"},{"key":"10.1016\/j.heliyon.2023.e17478_bib237","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2015.01230","article-title":"Melatonin: current status and future perspectives in plant science","volume":"6","author":"Nawaz","year":"2016","journal-title":"Front. Plant Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib238","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1556-7","article-title":"Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care","volume":"10","author":"Tarocco","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2023.e17478_bib239","unstructured":"Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers\u201d."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17478_bib240","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-9-129","article-title":"Anti-inflammatory effects of nicotine in obesity and ulcerative colitis","volume":"9","author":"Lakhan","year":"2011","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17478_bib241","article-title":"Nicotine modifies cytokine production by human mononuclears stimulated by colon cancer cells","volume":"3","author":"M","year":"2017","journal-title":"Colorectal Cancer: Open Access"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17478_bib242","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e17478_bib243","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.intimp.2018.11.049","article-title":"Gallic acid improved inflammation via NF-\u03baB pathway in TNBS-induced ulcerative colitis","volume":"67","author":"Zhu","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2023.e17478_bib244","doi-asserted-by":"crossref","unstructured":"S. H. Kim et al., \u201cGallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells,\u201d Toxicol. Sci., vol. 91, no. 1, pp. 123\u2013131, May 2006, doi: 10.1093\/toxsci\/kfj063.","DOI":"10.1093\/toxsci\/kfj063"},{"key":"10.1016\/j.heliyon.2023.e17478_bib245","series-title":"E\u0160ect of Gallic Acid Derivatives on Secretion of Th1 Cytokines and Th2 Cytokines from Anti CD3-Stimulated Spleen Cells","author":"\u6176\u52a0\u85e4","year":"2001"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib246","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.13005\/bpj\/1514","article-title":"Effects of gallic acid and its derivates on inflammatory regulation of endometriotic primary cultures: study on NF-kB mRNA expression and IL-6 secretion","volume":"11","author":"Bustami","year":"2018","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.heliyon.2023.e17478_bib247","series-title":"The Enzymatic Poly(gallic Acid) Reduces Pro-inflammatory Cytokines in Vitro, a Potential Application in Inflammatory Diseases","author":"Zamudio-Cuevas","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e17478_bib248","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/B978-0-323-46144-3.00028-3","article-title":"Natural plant-derived anticancer drugs nanotherapeutics: a review on preclinical to clinical success","author":"Varsha","year":"2017","journal-title":"Nanostruct. Cancer Ther."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17478_bib249","first-page":"3602","article-title":"A review on herbal plants as immunomodulators","volume":"7","author":"Singh","year":"2016","journal-title":"Int. J. Pharma Sci. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17478_bib250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/08923970902783092","article-title":"Effects of scrocaffeside A from Picrorhiza Scrophulariiflora on immunocyte function in vitro","volume":"31","author":"An","year":"2009","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17478_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym12102338","article-title":"Immunomodulatory and anti\u2010inflammatory effects of fucoidan: a review","volume":"12","author":"Apostolova","year":"2020","journal-title":"Polymers"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17478_bib252","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1021\/np9003678","article-title":"Oxygenated lignans from the fruits of Schisandra arisanensis","volume":"72","author":"Bin Cheng","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.heliyon.2023.e17478_bib253","article-title":"Natural products and nanotechnology against coronavirus disease","volume":"10","author":"Zeng","year":"2019","journal-title":"Front. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023046868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023046868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:22:50Z","timestamp":1790468570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023046868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":253,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405844023046868"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17478","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plausibility of natural immunomodulators in the treatment of COVID-19\u2013A comprehensive analysis and future recommendations","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17478"}}